Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: A Gynecologic Oncology Group Study

Gynecologic Oncology

Volumn 94, Issue 2, 2004, Pages 495-501

  Winter III, William E ^a   Maxwel, G Larry ^a   Tian, Chunqiao ^b   Sobel, Eugene ^b   Scott Rose, G ^a   Thomas, Gillian ^c   Carlson, Jay W ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Cervical cancer; Chemoradiation; Hemoglobin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 3543083957     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.04.008     Document Type: Article

References (12)

1. Thomas A., Jemal A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J. Clin. 52(1):2002;23-47
2. SEER cancer incidence public use database, 1973-1994. 1997;National Cancer Institute, Bethesda, MD. software
3. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340(15):1999;1144-1153
4. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., et al. Pelvic radiation with chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340:1999;1137-1143
5. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340:1999;1154-1161
6. Peters W.A., Lu P.Y., Barrett R.J., Stock R.J., Monk B.J., Berek J.S. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. N. Engl. J. Med. 18:2000;1606-1613
7. Girinski T., Pejovic-Lenfant M.H., Bourhis J., Campana F., Cosset J.M., Petit C., et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;37-42
8. Grogan M., Thomas G.M., Melamed I., Wong F.L., Pearcey R.G., Joseph P.K., et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer. 86:1999;1528-1536
9. Obermair A., Cheuk R., Horwood K., Janda M., Bachtiary B., Schwanzelberger B., et al. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer. 92:2001;903-908
10. Harrison L., Shasha D., Shiaova L., White C., Ramdeen B., Portenoy R. Prevalence of anemia in cancer patients undergoing radiation therapy. Semin. Oncol. 28(2 Suppl 8):2001;54-59
11. Katz A., Eifel P.J., Moughan J., Owen J.B., Mahon I., Hanks G.E. Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study. Int. J. Radiat. Oncol. Biol. Phys. 47(2):2000;443-450
12. Kallman R.F. The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology. 105:1972;135